311 related articles for article (PubMed ID: 30003350)
1. Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study.
Lim C; Osseis M; Lahat E; Doussot A; Sotirov D; Hemery F; Lantéri-Minet M; Feray C; Salloum C; Azoulay D
Surg Endosc; 2019 Mar; 33(3):811-820. PubMed ID: 30003350
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Liver Resection for Hepatocellular Carcinoma in Child-Pugh A Patients With and Without Portal Hypertension: A Multicentre Study.
Casellas-Robert M; Lim C; Lopez-Ben S; Lladó L; Salloum C; Codina-Font J; Comas-Cufí M; Ramos E; Figueras J; Azoulay D
World J Surg; 2020 Nov; 44(11):3915-3922. PubMed ID: 32661688
[TBL] [Abstract][Full Text] [Related]
3. Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study.
Molina V; Sampson-Dávila J; Ferrer J; Fondevila C; Díaz Del Gobbo R; Calatayud D; Bruix J; García-Valdecasas JC; Fuster J
Surg Endosc; 2018 May; 32(5):2345-2354. PubMed ID: 29218665
[TBL] [Abstract][Full Text] [Related]
4. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.
Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X
Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
[TBL] [Abstract][Full Text] [Related]
6. Impact and outcomes of liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
Cortese S; Tellado JM
Cir Cir; 2022; 90(5):579-587. PubMed ID: 36327469
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach.
Shinkawa H; Kaibori M; Kabata D; Nakai T; Ueno M; Hokuto D; Ikoma H; Iida H; Komeda K; Tanaka S; Kosaka H; Nobori C; Hayami S; Yasuda S; Morimura R; Mori H; Kagota S; Kubo S; Ishizawa T
Surg Endosc; 2024 Feb; 38(2):757-768. PubMed ID: 38052887
[TBL] [Abstract][Full Text] [Related]
8. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis.
Chen X; Zhai J; Cai X; Zhang Y; Wei L; Shi L; Wu D; Shen F; Lau WY; Wu M
Br J Surg; 2012 Dec; 99(12):1701-10. PubMed ID: 23132418
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience.
Coletta D; De Padua C; Parrino C; De Peppo V; Oddi A; Frigieri C; Grazi GL
J Laparoendosc Adv Surg Tech A; 2020 Oct; 30(10):1054-1065. PubMed ID: 32707003
[No Abstract] [Full Text] [Related]
10. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
Yu H; Zhao F; Men X; Zhu H; Yan J; Liu Z; Liu Q; Feng Y; Wang L; Meng M; Zhu Q; Zhao X
Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis.
Xiang ZQ; Wu YC; Qu XL; Luo DJ; Liang H; Ameer S; Long ZT; Dai XM; Zhu Z
World J Surg Oncol; 2024 Jan; 22(1):3. PubMed ID: 38166925
[TBL] [Abstract][Full Text] [Related]
12. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
Liu J; Zhang H; Xia Y; Yang T; Gao Y; Li J; Wu Y; Shen F
HPB (Oxford); 2019 Jan; 21(1):1-13. PubMed ID: 30082213
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single-center experience.
Shehta A; Han HS; Yoon YS; Cho JY; Choi Y
Surg Endosc; 2016 Feb; 30(2):638-648. PubMed ID: 26091992
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic Versus Open Hepatic Resection for Solitary Hepatocellular Carcinoma Less Than 5 cm in Cirrhotic Patients: A Randomized Controlled Study.
El-Gendi A; El-Shafei M; El-Gendi S; Shawky A
J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):302-310. PubMed ID: 29172949
[TBL] [Abstract][Full Text] [Related]
15. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
[TBL] [Abstract][Full Text] [Related]
16. Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
Azoulay D; Ramos E; Casellas-Robert M; Salloum C; Lladó L; Nadler R; Busquets J; Caula-Freixa C; Mils K; Lopez-Ben S; Figueras J; Lim C
JHEP Rep; 2021 Feb; 3(1):100190. PubMed ID: 33294830
[TBL] [Abstract][Full Text] [Related]
17. Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma.
Lopez-Lopez V; Brusadin R; López-Conesa A; Capel A; Navarro-Barrios Á; Cayuela V; Lopez-Banet E; Garzón-Arana A; Parrilla-Paricio P; Robles-Campos R
Langenbecks Arch Surg; 2021 May; 406(3):763-771. PubMed ID: 33411038
[TBL] [Abstract][Full Text] [Related]
18. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors.
Llop E; Berzigotti A; Reig M; Erice E; Reverter E; Seijo S; Abraldes JG; Bruix J; Bosch J; García-Pagan JC
J Hepatol; 2012 Jan; 56(1):103-8. PubMed ID: 21827733
[TBL] [Abstract][Full Text] [Related]
19. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
[TBL] [Abstract][Full Text] [Related]
20. Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.
Di Sandro S; Bagnardi V; Najjar M; Buscemi V; Lauterio A; De Carlis R; Danieli M; Pinotti E; Benuzzi L; De Carlis L
Surg Oncol; 2018 Dec; 27(4):722-729. PubMed ID: 30449499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
